Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine.
University of Miami Miller School of Medicine, Miami, FL.
J Craniofac Surg. 2023 Oct 1;34(7):2016-2025. doi: 10.1097/SCS.0000000000009593. Epub 2023 Aug 28.
Bone tissue regeneration is a complex process that proceeds along the well-established wound healing pathway of hemostasis, inflammation, proliferation, and remodeling. Recently, tissue engineering efforts have focused on the application of biological and technological principles for the development of soft and hard tissue substitutes. Aim is directed towards boosting pathways of the healing process to restore form and function of tissue deficits. Continued development of synthetic scaffolds, cell therapies, and signaling biomolecules seeks to minimize the need for autografting. Despite being the current gold standard treatment, it is limited by donor sites' size and shape, as well as donor site morbidity. Since the advent of computer-aided design/computer-aided manufacturing (CAD/CAM) and additive manufacturing (AM) techniques (3D printing), bioengineering has expanded markedly while continuing to present innovative approaches to oral and craniofacial skeletal reconstruction. Prime examples include customizable, high-strength, load bearing, bioactive ceramic scaffolds. Porous macro- and micro-architecture along with the surface topography of 3D printed scaffolds favors osteoconduction and vascular in-growth, as well as the incorporation of stem and/or other osteoprogenitor cells and growth factors. This includes platelet concentrates (PCs), bone morphogenetic proteins (BMPs), and some pharmacological agents, such as dipyridamole (DIPY), an adenosine A 2A receptor indirect agonist that enhances osteogenic and osteoinductive capacity, thus improving bone formation. This two-part review commences by presenting current biological and engineering principles of bone regeneration utilized to produce 3D-printed ceramic scaffolds with the goal to create a viable alternative to autografts for craniofacial skeleton reconstruction. Part II comprehensively examines recent preclinical data to elucidate the potential clinical translation of such 3D-printed ceramic scaffolds.
骨组织再生是一个复杂的过程,沿着已确立的止血、炎症、增殖和重塑的伤口愈合途径进行。最近,组织工程的努力集中在应用生物和技术原理来开发软、硬组织替代物。目标是促进愈合过程的途径,以恢复组织缺陷的形态和功能。持续开发合成支架、细胞疗法和信号生物分子旨在减少对自体移植物的需求。尽管自体移植物是目前的金标准治疗方法,但它受到供体部位的大小和形状以及供体部位发病率的限制。自从计算机辅助设计/计算机辅助制造 (CAD/CAM) 和增材制造 (AM) 技术(3D 打印)出现以来,生物工程显著扩展,同时继续为口腔和颅面骨骼重建提供创新方法。主要例子包括可定制、高强度、承载负荷、生物活性陶瓷支架。3D 打印支架的多孔宏观和微观结构以及表面形貌有利于骨传导和血管内生长,以及干细胞和/或其他成骨前体细胞和生长因子的掺入。这包括血小板浓缩物 (PCs)、骨形态发生蛋白 (BMPs) 和一些药理学药物,如双嘧达莫 (DIPY),一种腺苷 A 2A 受体间接激动剂,可增强成骨和诱导成骨能力,从而改善骨形成。这篇两部分的综述首先介绍了用于生产 3D 打印陶瓷支架的当前骨再生的生物学和工程原理,目标是为颅面骨骼重建创造一种可行的自体移植物替代物。第二部分全面检查了最近的临床前数据,以阐明此类 3D 打印陶瓷支架的潜在临床转化。